Innate and adaptive immunity during SARS-CoV-2 infection: biomolecular cellular markers and mechanisms

B Brown, V Ojha, I Fricke, SA Al-Sheboul, C Imarogbe… - Vaccines, 2023 - mdpi.com
The coronavirus 2019 (COVID-19) pandemic was caused by a positive sense single-
stranded RNA (ssRNA) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

The characterization of CD8+ T-cell responses in COVID-19

Y Yang, H Miller, MG Byazrova, F Cndotti… - Emerging Microbes & …, 2024 - Taylor & Francis
This review gives an overview of the protective role of CD8+ T cells in SARS-CoV-2
infection. The cross-reactive responses intermediated by CD8+ T cells in unexposed cohorts …

Pediatric systemic lupus erythematous in COVID-19 era

A Lupu, IC Miron, C Gavrilovici, AA Raileanu… - Viruses, 2023 - mdpi.com
Pediatric systemic lupus erythematosus is a chronic autoimmune disorder with a highly
variable course and prognosis. It results in functional abnormalities in the immune system …

Immune monitoring of SARS-CoV-2-specific T cell and B cell responses in patients with multiple sclerosis treated with ocrelizumab

E Groß-Albenhausen, A Weier, M Velten… - Frontiers in …, 2023 - frontiersin.org
Introduction Since the development of the coronavirus disease (COVID-19) pandemic
caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), there has …

Parainfluenza virus 5 is a next‐generation vaccine vector for human infectious pathogens

T Wang, L Zheng, Q Zhao, Y Yao… - Journal of Medical …, 2023 - Wiley Online Library
Abstract Parainfluenza virus 5 (PIV5) is a negative‐sense, single‐stranded RNA virus that
can infect humans and many species of animals. Infection in these reservoir hosts is …

[HTML][HTML] Functional and structural investigation of a broadly neutralizing SARS-CoV-2 antibody

YH Chang, MF Hsu, WN Chen, MH Wu, WL Kong… - JCI insight, 2024 - ncbi.nlm.nih.gov
Since its emergence, SARS-CoV-2 has been continuously evolving, hampering the
effectiveness of current vaccines against COVID-19. mAbs can be used to treat patients at …

Protection against Severe Illness versus Immunity—Redefining Vaccine Effectiveness in the Aftermath of COVID-19

R Roche, NH Odeh, AU Andar, ME Tulapurkar… - Microorganisms, 2023 - mdpi.com
Anti-SARS-CoV-2 vaccines have played a pivotal role in reducing the risk of developing
severe illness from COVID-19, thus helping end the COVID-19 global public health …

Impaired immune response against SARS-CoV-2 infection is the major factor indirectly altering reproductive function in COVID-19 patients: a narrative review

KP Muyayalo, GS Gong, K Kiyonga Aimeé… - Human Fertility, 2023 - Taylor & Francis
Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease affecting multiple
systems and organs, including the reproductive system. SARS-CoV-2, the virus that causes …

Non-cross-reactive epitopes dominate the humoral immune response to COVID-19 vaccination–kinetics of plasma antibodies, plasmablasts and memory B cells

KA Wietschel, K Fechtner, E Antileo… - Frontiers in …, 2024 - frontiersin.org
Introduction COVID-19 vaccines are highly effective in inducing protective immunity. While
the serum antibody response to COVID-19 vaccination has been studied in depth, our …

Rationale for combined therapies in severe-to-critical COVID-19 patients

A Gonzaga, E Andreu, LM Hernandez-Blasco… - Frontiers in …, 2023 - frontiersin.org
An unprecedented global social and economic impact as well as a significant number of
fatalities have been brought on by the coronavirus disease 2019 (COVID-19), produced by …